A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis

KA34 - Scripps Research Institute, California Institute for Regenerative Medicine

http://clinicaltrials.gov/ct2/show/NCT03133676

Apr 30, 2020